Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia

Published:2005-09-15 Issue:11 Volume:19 Page:2009-2010
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Sonoki T,Iwanaga E,Mitsuya H,Asou N

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403938.pdf

Reference8 articles.

1. Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.

2. Ambros V . The functions of animal microRNAs. Nature 2004; 431: 350–355.

3. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31–q32 amplification in malignant lymphoma. Cancer Res 2004; 64: 3087–3095.

4. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T . Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735–739.

5. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828–833.

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Importance of Selected Dysregulated microRNAs in Diagnosis and Prognosis of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia;Cancers;2023-01-09

2. Different classes of genomic inserts contribute to human antibody diversity;Proceedings of the National Academy of Sciences;2022-08-29

3. miRNAs in Lymphocytic Leukaemias—The miRror of Drug Resistance;International Journal of Molecular Sciences;2022-04-22

4. Essential functions of miR‐125b in cancer;Cell Proliferation;2020-12-17

5. Targeting microRNA in hematologic malignancies;Current Opinion in Oncology;2020-07-10